CD4 and B-cell chronic lymphocytic leukemia: Moreover, Melenhorst and colleagues recently reported in a seminal paper a highly activated CD4+ population dominating the CAR T cell population at the later time points in two CLL patients with a decade-long remission post CAR T treatment [48].